World Journal of Urology

, Volume 37, Issue 2, pp 337–342 | Cite as

Factors influencing urinary retention after transperineal template biopsy of the prostate: outcomes from a regional cancer centre

  • Francesca KumEmail author
  • Adam Jones
  • Raj Nigam
Original Article



Multi-parametric MRI (MP-MRI) prior to prostate biopsy is the investigation of choice for an elevated age-related PSA and abnormal digital rectal examination. MP-MRI in combination with transperineal template mapping biopsy has facilitated the development of the concept of targeted biopsies, either cognitively or with software fusion. Urinary retention is a recognised complication of transperineal prostate biopsy, with reported incidence being 1.6–11.4%. We present patient and procedure-related factors, which influence occurrence of urinary retention after transperineal template biopsy.

Patients and methods

Retrospective data collection of 243 consecutive cases of transperineal template biopsies performed at a single institution were recorded and analysed. Biopsies were taken using a standard 5-mm template in 4–6 sectors, depending on the prostate volume.


31/243 (12.8%) patients developed urinary retention, defined as patient discomfort and inability to micturate and bladder scan of ≥ 600 ml. Patients in the retention group were significantly older (mean 68.7 vs. 65.8 years, P = 0.034). Prostate volume was significantly greater in comparison with the non-retention group (mean 75.4 vs. 57.2 cc, P = 0.0016). The number of biopsies taken was positively correlated with urinary retention (median 35 vs. 32 biopsies, P = 0.045), and this was independent of prostate size (R2 = 0.2). Presenting PSA, pre-operative flow and histopathological outcome were independent of urinary retention.


Factors resulting in an increased risk of urinary retention are advancing age (> 68.7 years); a larger prostate volume (> 75 cc); greater number of biopsies (> 35); greater severity of lower urinary tract symptoms prior to biopsy and diabetes. Targeted biopsies alone, instead of a full template, may avoid urinary retention in the high-risk groups identified.


Transperineal template biopsy Prostate biopsy Prostate cancer Urinary retention 


Compliance with ethical standards

Conflict of interest

The authors declare that there are no conflicts of interest.


  1. 1.
    National Institute for Health and Care Excellence (2014) Prostate cancer: diagnosis and management. [CG175]. Accessed June 2017
  2. 2.
    Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822CrossRefGoogle Scholar
  3. 3.
    Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL et al (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level ≤ 4.0 ng per milliliter. N Engl J Med 350(22):2239–2246CrossRefGoogle Scholar
  4. 4.
    Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64(6):876–892CrossRefGoogle Scholar
  5. 5.
    Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S et al (2017) Complications after systematic, random, and image-guided prostate biopsy. Eur Urol 71(3):353–365CrossRefGoogle Scholar
  6. 6.
    Ghai S, Haider MA (2015) Multiparametric-MRI in diagnosis of prostate cancer. Indian J Urol 31(3):194–201CrossRefGoogle Scholar
  7. 7.
    National Institute for Health and Care Excellence (2010) Transperineal template biopsy and mapping of the prostate: interventional procedures guidance. [IPG364]. Accessed June 2017
  8. 8.
    Bott SR, Henderson A, Halls JE, Montgomery BS, Laing R, Langley SE (2006) Extensive transperineal template biopsies of prostate: modified technique and results. Urology 68(5):1037–1041CrossRefGoogle Scholar
  9. 9.
    National Institute for Health and Care Excellence (2009) Interventional procedures programme: Interventional procedure overview of transperineal template biopsy and mapping of the prostate. [IP793]. Accessed June 2017
  10. 10.
    Serefoglu EC, Altinova S, Ugras NS, Akincioglu E, Asil E, Balbay MD (2012) How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? Can Urol Assoc J 7(5–6):E293–E298Google Scholar
  11. 11.
    Pepe P, Garufi A, Priolo G, Pennisi M (2017) Transperineal versus transrectal MRI/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer. Clin Genitourin Cancer 15(1):e33–e36CrossRefGoogle Scholar
  12. 12.
    Smith JB, Popert R, Nuttall MC, Vyas L, Kinsella J, Cahill D (2014) Transperineal sector prostate biopsies: a local anesthetic outpatient technique. Urology 83(6):1344–1349CrossRefGoogle Scholar
  13. 13.
    Pinkstaff DM, Igel TC, Petrou SP, Broderick GA, Wehle MJ, Young PR (2005) Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. Urology 65(4):735–739CrossRefGoogle Scholar
  14. 14.
    Pepe P, Aragona F (2013) Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs. 18 vs. more than 24 needle cores. Urology 81(6):1142–1146CrossRefGoogle Scholar
  15. 15.
    Merrick GS, Taubenslag W, Andreini H, Brammer S, Butler WM, Adamovich E, Allen Z, Anderson R, Wallner KE (2008) The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 101(12):1524–1529CrossRefGoogle Scholar
  16. 16.
    Buskirk SJ, Pinkstaff DM, Petrou SP, Wehle MJ, Broderick GA, Young PR et al (2004) Acute urinary retention after transperineal template-guided prostate biopsy. Int J Radiat Oncol Biol Phys 59(5):1360–1366CrossRefGoogle Scholar
  17. 17.
    Willis S, Bott S, Montgomery B (2012) Urinary retention following transperineal template prostate biopsy—study of risk factors. J Clin Urol 6(1):55–58CrossRefGoogle Scholar
  18. 18.
    Huang S, Reeves F, Preece J, Satasivam P, Royce P, Grummet JP (2015) Significant impact of transperineal template biopsy of the prostate at a single tertiary institution. Urol Ann 7(4):428–432CrossRefGoogle Scholar
  19. 19.
    Taira AV, Merrick GS, Galbreath RW, Andreini H, Taubenslag W, Curtis R et al (2009) Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis 13(1):71–77CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Urology (c/o Mr Raj Nigam)Royal Surrey County HospitalGuildfordUK

Personalised recommendations